Breathe Easier. Live Better.
Innovation in the Treatment of COPD/Emphysema
Our Approach
To pioneer a groundbreaking, patient-centered treatment for COPD/Emphysema that offers lung volume reduction while preserving healthy lung tissue and broadening the range of patients eligible for effective treatment.
Dedicated to offering healthcare professionals and patients a safe and effective technique, especially for those with few remaining treatment options.
Our Device
The Pulmair Medical "Implantable Artificial Bronchus" (IAB) is a novel airway device that is implanted bronchoscopically by interventional pulmonologists using a proprietary delivery system into diseased lungs of patients with COPD/Emphysema.
Our Leadership Team
-
Marcelo G. Lima
Chairman, President & CEO
-
Herbert Radisch
VP of Engineering & CTO
-
Tracey Kruger
VP BD and Clin Ops
-
Paul Mason
Regulatory Affairs
“It’s incredibly rewarding to know that our technology has the potential t0 make a real difference in people’s lives. Helping patients breathe easier, feel more comfortable, and experience a better quality of life is why we do what we do. This device is not only designed to be safe but also to provide lasting relief—something that is extremely important to us. Knowing that our work will improve lives keeps us focused on our mission to help everyone breathe better."
— MARCELO G. LIMA, Chairman, President & CEO